Complement Emerges as Central Player and Drug Target in Neurological Disease
A new Nature Reviews Neurology review details how the complement system drives autoimmune and neurodegenerative neurological diseases and how a ...
A new Nature Reviews Neurology review details how the complement system drives autoimmune and neurodegenerative neurological diseases and how a ...
A phase III trial of obinutuzumab β shows striking efficacy in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorder, deepening questions about which ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine